Stock Analysis

Some Investors May Be Willing To Look Past HYUNDAI BIOLANDLtd's (KOSDAQ:052260) Soft Earnings

KOSDAQ:A052260
Source: Shutterstock

The market for HYUNDAI BIOLAND Co.,Ltd.'s (KOSDAQ:052260) shares didn't move much after it posted weak earnings recently. We did some digging, and we believe the earnings are stronger than they seem.

View our latest analysis for HYUNDAI BIOLANDLtd

earnings-and-revenue-history
KOSDAQ:A052260 Earnings and Revenue History March 18th 2025

How Do Unusual Items Influence Profit?

Importantly, our data indicates that HYUNDAI BIOLANDLtd's profit was reduced by ₩2.8b, due to unusual items, over the last year. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. If HYUNDAI BIOLANDLtd doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On HYUNDAI BIOLANDLtd's Profit Performance

Unusual items (expenses) detracted from HYUNDAI BIOLANDLtd's earnings over the last year, but we might see an improvement next year. Because of this, we think HYUNDAI BIOLANDLtd's earnings potential is at least as good as it seems, and maybe even better! On the other hand, its EPS actually shrunk in the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. You'd be interested to know, that we found 1 warning sign for HYUNDAI BIOLANDLtd and you'll want to know about this.

This note has only looked at a single factor that sheds light on the nature of HYUNDAI BIOLANDLtd's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

Valuation is complex, but we're here to simplify it.

Discover if HYUNDAI BIOLANDLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About KOSDAQ:A052260

HYUNDAI BIOLANDLtd

Engages in the manufacture and sale of natural materials for cosmetics, nutraceuticals, and regenerative medicines worldwide.

Undervalued with excellent balance sheet.